Literature DB >> 18077714

Intracellular localization map of human herpesvirus 8 proteins.

Gaby Sander1, Andreas Konrad, Mathias Thurau, Effi Wies, Rene Leubert, Elisabeth Kremmer, Holger Dinkel, Thomas Schulz, Frank Neipel, Michael Stürzl.   

Abstract

Human herpesvirus 8 (HHV-8) is the etiological agent of Kaposi's sarcoma. We present a localization map of 85 HHV-8-encoded proteins in mammalian cells. Viral open reading frames were cloned with a Myc tag in expression plasmids, confirmed by full-length sequencing, and expressed in HeLa cells. Protein localizations were analyzed by immunofluorescence microscopy. Fifty-one percent of all proteins were localized in the cytoplasm, 22% were in the nucleus, and 27% were found in both compartments. Surprisingly, we detected viral FLIP (v-FLIP) in the nucleus and in the cytoplasm, whereas cellular FLIPs are generally localized exclusively in the cytoplasm. This suggested that v-FLIP may exert additional or alternative functions compared to cellular FLIPs. In addition, it has been shown recently that the K10 protein can bind to at least 15 different HHV-8 proteins. We noticed that K10 and only five of its 15 putative binding factors were localized in the nucleus when the proteins were expressed in HeLa cells individually. Interestingly, in coexpression experiments K10 colocalized with 87% (13 of 15) of its putative binding partners. Colocalization was induced by translocation of either K10 alone or both proteins. These results indicate active intracellular translocation processes in virus-infected cells. Specifically in this framework, the localization map may provide a useful reference to further elucidate the function of HHV-8-encoded genes in human diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077714      PMCID: PMC2258699          DOI: 10.1128/JVI.01716-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.

Authors:  S Ishido; C Wang; B S Lee; G B Cohen; J U Jung
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2.

Authors:  P M Ojala; K Yamamoto; E Castaños-Vélez; P Biberfeld; S J Korsmeyer; T P Mäkelä
Journal:  Nat Cell Biol       Date:  2000-11       Impact factor: 28.824

3.  Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.

Authors:  F Y Wu; J H Ahn; D J Alcendor; W J Jang; J Xiao; S D Hayward; G S Hayward
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?

Authors:  F Samaniego; S Pati; J E Karp; O Prakash; D Bose
Journal:  J Natl Cancer Inst Monogr       Date:  2001

6.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.

Authors:  L Coscoy; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.

Authors:  C Rivas; A E Thlick; C Parravicini; P S Moore; Y Chang
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Human herpesvirus 8 glycoprotein K8.1: expression, post-translational modification and localization analyzed by monoclonal antibody.

Authors:  L Wu; R Renne; D Ganem; B Forghani
Journal:  J Clin Virol       Date:  2000-08       Impact factor: 3.168

9.  Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein.

Authors:  Stéphanie Portes-Sentis; Evelyne Manet; Géraldine Gourru; Alain Sergeant; Henri Gruffat
Journal:  J Gen Virol       Date:  2001-03       Impact factor: 3.891

10.  Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1.

Authors:  B S Lee; X Alvarez; S Ishido; A A Lackner; J U Jung
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  39 in total

1.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Authors:  Katharina Heinzelmann; Barbara A Scholz; Agnes Nowak; Even Fossum; Elisabeth Kremmer; Juergen Haas; Ronald Frank; Bettina Kempkes
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

2.  Human cytomegalovirus UL76 elicits novel aggresome formation via interaction with S5a of the ubiquitin proteasome system.

Authors:  Shin-Rung Lin; Meei Jyh Jiang; Hung-Hsueh Wang; Cheng-Hui Hu; Ming-Shan Hsu; Edward Hsi; Chang-Yih Duh; Shang-Kwei Wang
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Authors:  Bizunesh Abere; Naira Samarina; Silvia Gramolelli; Jessica Rückert; Gisa Gerold; Andreas Pich; Thomas F Schulz
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.

Authors:  Katharina Schmidt; Effi Wies; Frank Neipel
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

5.  Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.

Authors:  Caitlin G Smith; Himanshu Kharkwal; Duncan W Wilson
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

6.  Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.

Authors:  Mathias Thurau; Gaby Marquardt; Nathalie Gonin-Laurent; Kristina Weinländer; Elisabeth Naschberger; Ramona Jochmann; Khaled R Alkharsah; Thomas F Schulz; Margot Thome; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

7.  Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein.

Authors:  Jian-jun Wu; Wenwei Li; Yaming Shao; Denis Avey; Bishi Fu; Joseph Gillen; Travis Hand; Siming Ma; Xia Liu; Wendell Miley; Andreas Konrad; Frank Neipel; Michael Stürzl; Denise Whitby; Hong Li; Fanxiu Zhu
Journal:  Cell Host Microbe       Date:  2015-08-27       Impact factor: 21.023

8.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

9.  Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.

Authors:  Denis Avey; Sarah Tepper; Benjamin Pifer; Amritpal Bahga; Hunter Williams; Joseph Gillen; Wenwei Li; Sarah Ogden; Fanxiu Zhu
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

10.  Fluorescent tagging and cellular distribution of the Kaposi's sarcoma-associated herpesvirus ORF45 tegument protein.

Authors:  Shir Bergson; Inna Kalt; Inbal Itzhak; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.